Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03815279 |
| Title | A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM) (iStopMM) |
| Acronym | iStopMM |
| Recruitment | Enrolling by invitation |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Landspitali University Hospital |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ISL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Landspitali University Hospital | Reykjavik | 101 | Iceland | Details |